0 projects

Selections based on text queries do not reflect the Research Council's published statistics


Text queries provide an overview of all projects containing the specified text in either its title or summary. This may result in a different selection of projects than that used by the Research Council as presented in its various publications. The Research Council's statistics are normally based on selections in set categories. You will find these in the left menu, in the diagrams themselves or when selecting from the left column of autocomplete suggestions via the search field.

BIA-Brukerstyrt innovasjonsarena

High-speed Turbidimetric Calprotectin Immunoassay - A New Rapid-response Biomarker for Sepsis and other Diseases and Conditions

...patents are pending in other jurisdictions. Gentian AS has been co-ordinator for a FP6 STREP...immunoassays based on in its new technology. Gentians annual turnover is 13 million NOK and...including blood, plasma and faecal extracts. Gentian has also invented a new method for antigen...

Awarded: NOK 5.0 mill.

Project Period: 2011-2014

Location: Viken

EUROSTARS-EUROSTARS

E!7991 Developing the Next Generation of Fecal Diagnostics

...community. Short Description: A pa tented Gentian high-speed prototype homogeneous...main goal of the project is to exploit a new Gentian European patent EP 1 739 430 and verify a...in hospitals and commercial laboratories. Gentian has created a strategic alliance with...

Awarded: NOK 4.2 mill.

Project Period: 2013-2017

Location: Viken

PES2020-Prosj.etabl.støtte H2020

Diagnostic test with novel ultra-sensitive technology

...Gentian has invented a technique that allows...

Awarded: NOK 74,999

Project Period: 2019-2019

Location: Viken

BIA-Brukerstyrt innovasjonsarena

Sepsis studies

...for accurate sepsis identification. The SME Gentian AS (Moss, Norway) has developed and patented...clinical studies. In this project, Gentian will work together with 3 national and...for nøyaktig sepsisidentifikasjon. SME Gentian AS (Moss, Norge) har utviklet og patentert...

Awarded: NOK 3.2 mill.

Project Period: 2019-2021

Location: Viken

PES2020-Prosj.etabl.støtte H2020

Feasibility study for a diagnostic test with novel ultra-sensitive technology

...Gentian has invented a technique that allows...

Awarded: NOK 49,999

Project Period: 2018-2018

Location: Viken

EUROSTARS-EUROSTARS

E!5727 New immunoassay technology for acute phase proteins for all mammals

...practice. New immunoassay technology: Gentian has made a prototype nanoparticle-based CRP...Gentian's New Immunoassay Technology for acute phase...is a Eurostars funded project involving Gentian Technology AS, the Swedish University of...

Awarded: NOK 4.7 mill.

Project Period: 2010-2013

Location: Viken

BIA-Brukerstyrt innovasjonsarena

Nyrefunksjonsmåling basert på måling av cystatin C i en enkelt fullblodsprøve

...knyttet til målingene av cystatin C. Gentian AS lanserte i 2006 et nytt...i Uppsala, Norwegian Antibodies AS og Gentian...

Awarded: NOK 4.0 mill.

Project Period: 2008-2011

Location: Viken

PES2020-Prosj.etabl.støtte H2020

Prepare fPELA-fHb Eurostars application

...companies, Norwegian Gentian AS and Swiss Bühlmann AG, will develop,...

Awarded: NOK 99,999

Project Period: 2018-2019

Location: Viken

BIA-Brukerstyrt innovasjonsarena

G-1001

...this project, Norwegian SME Gentian AS will further research, develop, optimize,... I dette prosjektet vil Norwegian SME Gentian AS videreutvikle, utvikle, optimalisere,...

Awarded: NOK 14.0 mill.

Project Period: 2020-2023

Location: Viken

PES2020-Prosj.etabl.støtte H2020

Super-Sensitive Particle Despersion ImmunoAssays, preparation for a second stage application for the H2020-PHC-2014-two-stage Program.

...per 19th of August 2014. Gentian Nanotech AS has made a prototype assay and...

Awarded: NOK 89,999

Project Period: 2014-2014

Location: Viken

BIA-Brukerstyrt innovasjonsarena

Produksjonsteknologi og prosess for Hurtigtester

...Man vil ta utgangspunkt i utviklingen til Gentian AS av en ny familie hurtige, billige...

Awarded: NOK 0.50 mill.

Project Period: 2017-2017

Location: Viken

EUROSTARS-EUROSTARS

E!8470 Veterinary point-of-care test device.

...animals are becoming available. For example, Gentian Technology will supply a specific canine CRP...

Awarded: NOK 5.9 mill.

Project Period: 2013-2017

Location: Viken

BIA-Brukerstyrt innovasjonsarena

Development of a novel high-throughput Sars-CoV-2 antibody test

...Gentian AS og Universitetet i Tromsø (UiT)/Norges...eller den faktiske negative frekvensen). Gentian SARS-CoV-2 Total Antibody Assay er et...

Awarded: NOK 8.0 mill.

Project Period: 2020-2022

Location: Viken

EUROSTARS-EUROSTARS

E!10602 Plasma ferritin immunoassay for whole blood samples

...på blodbanken og før han/hun gir blod. Gentian og Getica har gjennom dette...

Awarded: NOK 1.9 mill.

Project Period: 2016-2018

Location: Viken

PES2020-Prosj.etabl.støtte H2020

(PES) SpectroFlow: Instrument free Point-of-Care diagnostic system with central laboratory quality

...new POC system will also increase demand for Gentians equivalent laboratory-based tests (current...

Awarded: NOK 99,999

Project Period: 2020-2020

Location: Viken

BIOTEK2021-Bioteknologi for verdiskaping

ANTHOcyanin production PLatform Using Suspension cultures

...

Awarded: NOK 3.6 mill.

Project Period: 2014-2018

Location: Viken